Cargando…
Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) is an unmet medical need worldwide, and physical inactivity is a risk factor for AD. Performing physical exercise is difficult at old age, and thus, decline in physical movement may be a cause of age‐associated lowering of the brain function. This study aime...
Autores principales: | Nagase, Tsukasa, Tohda, Chihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718090/ https://www.ncbi.nlm.nih.gov/pubmed/34658156 http://dx.doi.org/10.1002/jcsm.12830 |
Ejemplares similares
-
New Treatment for Alzheimer's Disease, Kamikihito, Reverses Amyloid-β-Induced Progression of Tau Phosphorylation and Axonal Atrophy
por: Watari, Hidetoshi, et al.
Publicado: (2014) -
Hemopexin and Cancer
por: Fiorito, Veronica, et al.
Publicado: (2022) -
Acteoside Improves Muscle Atrophy and Motor Function by Inducing New Myokine Secretion in Chronic Spinal Cord Injury
por: Kodani, Atsushi, et al.
Publicado: (2019) -
Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology
por: Ashraf, Azhaar, et al.
Publicado: (2020) -
Low Cerebrospinal Fluid Levels of Hemopexin Are Associated With Increased Alzheimer's Pathology, Hippocampal Hypometabolism, and Cognitive Decline
por: Ashraf, Azhaar A., et al.
Publicado: (2020)